Rockland Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $274K | Sell |
3,497
-658
| -16% | -$51.5K | 0.01% | 224 |
|
|
2025
Q1 | $301K | Sell |
4,155
-198
| -5% | -$14.4K | 0.02% | 221 |
|
|
2024
Q4 | $322K | Buy |
4,353
+334
| +8% | +$24.7K | 0.02% | 226 |
|
|
2024
Q3 | $265K | Hold |
4,019
| – | – | 0.01% | 245 |
|
|
2024
Q2 | $371K | Sell |
4,019
-1,162
| -22% | -$107K | 0.02% | 228 |
|
|
2024
Q1 | $495K | Sell |
5,181
-4,208
| -45% | -$402K | 0.03% | 203 |
|
|
2023
Q4 | $716K | Buy |
9,389
+1,160
| +14% | +$88.5K | 0.04% | 170 |
|
|
2023
Q3 | $570K | Sell |
8,229
-390
| -5% | -$27K | 0.03% | 186 |
|
|
2023
Q2 | $813K | Sell |
8,619
-20
| -0.2% | -$1.89K | 0.05% | 160 |
|
|
2023
Q1 | $715K | Buy |
8,639
+122
| +1% | +$10.1K | 0.04% | 166 |
|
|
2022
Q4 | $635K | Buy |
8,517
+2,040
| +31% | +$152K | 0.04% | 184 |
|
|
2022
Q3 | $535K | Sell |
6,477
-901
| -12% | -$74.4K | 0.04% | 174 |
|
|
2022
Q2 | $702K | Buy |
7,378
+942
| +15% | +$89.6K | 0.05% | 155 |
|
|
2022
Q1 | $758K | Sell |
6,436
-501
| -7% | -$59K | 0.05% | 164 |
|
|
2021
Q4 | $899K | Buy |
6,937
+5,097
| +277% | +$661K | 0.06% | 157 |
|
|
2021
Q3 | $208K | Buy |
+1,840
| New | +$208K | 0.01% | 274 |
|